NewsDesk @bactiman63

The Health Emergency Response Operations Center (CORUS) informs that 89 cases of chikungunya have been confirmed in Pouytenga in the Center-East region of Burkina Faso by the national viral hemorrhagic fever reference laboratory (LNR/FHV) at the MURAZ center .


“On September 6, 2023, the viral hemorrhagic fever reference laboratory confirmed a case of Chikungunya in a patient from the Pouytenga health district whose sample was taken as part of sentinel surveillance for dengue and other arboviruses. The patient is 30 years old and lives in sector 2 of Pouytenga in the Center East region. The patient has not traveled in the last 14 days. The start date of the signs would be August 19, 2023. She presented with an acute fever with a temperature of 39°C, headache and joint pain.

Autochthonous dengue cases in Europe in 2023 to date

The malaria RDT result was positive. The thick film was negative. The patient was hospitalized and put on treatment. The LNR-FHV received and tested positive for the Chikungunya virus case by RT-PCR,” indicates the CORUS note.



















According to the WHO, chikungunya is a viral disease transmitted to humans through the bites of mosquitoes infected with the chikungunya virus. It was first described during an outbreak in southern Tanzania in 1952 and has now been identified in nearly 40 countries in Asia, Africa, Europe and, most recently, the Americas. Symptoms usually begin 4 to 8 days after a mosquito bite but can appear anywhere from 2 to 12 days.

Subscribe to Outbreak News TV on YouTube

The most common symptom is an abrupt onset of fever, often accompanied by joint pain. Other symptoms include muscle pain, headache, nausea, fatigue, and rash. Severe joint pain usually lasts a few days but can persist for months or even years. Serious complications are uncommon, but atypical severe cases can cause long-term symptoms and even death, especially in older people.